You have two options:
Tile the forested mountains with black silicon panels and get 50-100 megawatts for 25-30 years.
Put a BWRX-300 in an IKEA-sized building and get 290 megawatts for 60-80 years.
Which is better for the environment?
We now use 20 fractions for prostate bed radiotherapy: Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-R… https://t.co/Una7ewsrKX
So honoured to have been part of the PACE team for the last 12 years. I have learned so much from @nickva1@EmmaHall71 and the whole team. Thanks to the 874 men and over 30 hospitals who partnered with us and to Accuray for funding. Abstract here https://t.co/OYASFeLJlI
#Confidence in #NuclearEnergy
Fear of #radiation is not justified by evidence of harm and should not obstruct the path to future #prosperity for our children and grandchildren.
https://t.co/qre7A4kB8c
CANDU nuclear produces Cobalt 60 which sterilizes 40% of the worlds single use medical devices but @s_guilbeault lumped it in with “sin stocks” like guns, gambling, tobacco & alcohol to exclude it from Green finance. Sign petition if you disagree https://t.co/blH2wxFvll
We built this for you, our Pickering #CANDU 🇨🇦 Nuclear Plant.
Even back in the environmental dark ages, we knew it was a much better choice than a coal fired plant. Clean #nuclearenergy for everyone, for Toronto, for Ontario, for Canada, for the future.
Then it was your turn.
I’ll keep saying this. It’s already perfectly possible to do this already with chemoRT. Adding IO may improve this (or not, we will see, trials are in progress). Bladder preservation should not be seen as something radical and new but a current valid option
Of 298 RCTs "in the Era of Precision Oncology":
🔴42% had PFS as 1° endpoint;
🔴89% [sic!] funded by industry;
🔴In 2020, 12/18 (67%) used prof. medical writer.
TBL➡️strong, independent, academic, clinical research more important than ever🤨
https://t.co/7vQFGekKDX
What is the clinical benefit of cancer drugs recommended for provincial reimbursement in Canada? New study from @oncology_bg and colleagues explores the answer to this question https://t.co/LgInHSgioK
Also NEW: randomised phase 2 trial: high-dose vs standard-dose twice-daily thoracic #radiotherapy for patients with limited stage small-cell #lungcancer#SCLC#lcsm https://t.co/H9dP5h9bkt
Nice job, Canada – the COVID Alert App is at the top of the iPhone and Google Play App Charts.
Every download makes it stronger. So if you don’t have it yet, add it to your phone today!
iPhone: https://t.co/fh0Gr4v4y3
Android: https://t.co/nSW37w9ZtB
RAVES, GETUG-AFU 17, RADICALS-RT and the ARTISTIC meta-analysis (Adjuvant RT vs. Salvage RT). All the articles in one tweet. @urotoday@oncoalert@PCaParker https://t.co/cw6ZoEdOXo
https://t.co/rVcvVtdJBN
https://t.co/lkRZW4lXA5
https://t.co/InnDkgQmj6
We must make it as easy or preferable for potential participants to enroll in a trial of a potentially worthwhile treatment as it is to prescribe the same unproven treatment.